The Centre for Clinical Studies runs early stage clinical trials for some of the world’s leading pharmaceutical and biotechnology companies. In order for new medications to make it onto the market, they must first undergo meticulous testing to determine overall safety and effectiveness. Here at the Centre for Clinical studies we facilitate these studies in-house, from the largest clinical trial unit in Australia.
We are the most experienced first in human and early phase clinical trial centre in Australia. Based in Melbourne, an internationally recognised city for its world-class infrastructure, we reside on the AMREP precinct (Alfred Hospital) with panoramic views of the Melbourne skyline.
We conduct our clinical studies with either healthy or patient volunteers. Healthy volunteers are individuals who meet the criteria for being healthy. Patient volunteers have specific medical conditions for which we are investigating new or improved treatments. Without volunteers, the development of new medication would not be possible.
The Centre for Clinical Studies is a division of Nucleus Network.
Nucleus Network is Australia’s leading clinical research organisation for the conduct of early phase clinical trials. Since its inception in 2003, we have developed a wealth of experience in complex, first-in-human studies. Within our state-of-the-art 80 bed facility we have conducted over 500 Phase I clinical trials over last 13 years.
Nucleus Network upholds stringent observation of international regulatory requirements. This facilitates the practice of the highest standards in clinical research. New drugs and compounds are administered in a controlled environment, and participants are attended to 24 hours a day by Nucleus Network’s experienced medical support staff.